Back
Vertex Pharmaceuticals Stock Predictions
AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!
Sell
49
VRTX
Vertex Pharmaceuticals
Last Price:
$490.03
Seasonality Move:
12.78%
7 Day Trial
ALL ACCESS PASS
$
7
Final Days: Should You Invest in This AI Startup Now?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.Vertex Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 26% based on the past 33 years of stock performance.
-
Vertex Pharmaceuticals has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Vertex Pharmaceuticals Stock Undervalued?The current Vertex Pharmaceuticals [VRTX] share price is $484.82. The Score for VRTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Vertex Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Vertex Pharmaceuticals has on average historically risen by 26% based on the past 33 years of stock performance.
Vertex Pharmaceuticals Stock Rating
Sell
49
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals overpriced?
-
Vertex Pharmaceuticals has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Vertex Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vrtx.com
52-Week Data
52-Week High:
519.88
52-Week Low:
377.85
Prediction Charts
Market Cap:
124.5B
Price in USD:
484.82
Volume:
2.2M
Beta:
0.95
Technical Analysis
SMA50:
474.16
SMA100:
462.38
SMA200:
470.09
52-Wk Change:
15.98%
Stock Predictions
-
Is Vertex Pharmaceuticals stock public?Yes, Vertex Pharmaceuticals is a publicly traded company.
-
What is the Vertex Pharmaceuticals stock quote today?The Vertex Pharmaceuticals stock price is 484.82 USD today.
-
How to buy Vertex Pharmaceuticals stock online?You can buy Vertex Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-12 | 484.62 | 495.42 | 496.64 | 483.09 |
| Mar-13 | 493.79 | 502.92 | 512.75 | 488.00 |
| Mar-14 | 507.00 | 504.77 | 519.68 | 502.26 |
| Mar-17 | 505.20 | 513.76 | 517.20 | 504.00 |
| Mar-18 | 513.08 | 512.23 | 516.50 | 508.52 |
| Mar-19 | 512.01 | 512.52 | 514.82 | 505.00 |
| Mar-20 | 509.99 | 510.18 | 515.67 | 505.49 |
| Mar-21 | 505.42 | 503.20 | 510.08 | 501.07 |
| Mar-24 | 505.00 | 511.74 | 513.98 | 501.00 |
| Mar-25 | 511.78 | 509.04 | 512.71 | 503.99 |
| Mar-26 | 504.87 | 500.28 | 508.64 | 497.78 |
| Mar-27 | 498.59 | 502.55 | 506.54 | 498.59 |
| Mar-28 | 504.79 | 492.69 | 504.79 | 491.37 |
| Mar-31 | 487.13 | 484.82 | 487.13 | 471.50 |
Vertex Pharmaceuticals Earnings
Vertex Pharmaceuticals Earnings Report: Per Share Vertex Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Vertex Pharmaceuticals Forecast Revenue Growth
Vertex Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Vertex Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.09 per share, an increase this year of $17.55 per share, and an increase next year of $2.36 per share.
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.